Sulfonamide compound
AssigneeAsahi Kasei Pharma Corporation
InventorsRintaro Yamada, Minoru Seto
Life of this patent
Estimating the term…
Loading patent…
AssigneeAsahi Kasei Pharma Corporation
InventorsRintaro Yamada, Minoru Seto
Estimating the term…
A compound represented by the formula (1) [A represents a nitrogen-containing saturated ring; m represents an integer of 0 to 2; n represents an integer of 1 to 4; G1 represents hydrogen atom, chlorine atom, hydroxyl group, an alkoxy group, or amino group; G2 represents a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, and the like; G3 represents hydrogen atom, a halogen atom, hydroxyl group, cyano group, carboxy group, an alkyl group, an alkenyl group, and the like; G4 represents hydroxyl group, or —N(R1)(R2) (R1 and R2 represent hydrogen atom, an alkyl group, an aralkyl group, an alkenyl group, an alkynyl group, or a saturated heterocyclic group); G5 is a substituent on a ring-constituting carbon atom of A, and represents hydrogen atom, fluorine atom, or an alkyl group] or a salt thereof, or a derivative thereof that is a prodrug, which potently inhibits phosphorylation of the myosin regulatory light chain.
A compound represented by the following general formula (1) or a salt thereof, or a derivative thereof which is a prodrug:
Dependencies are inferred from the claim text.